CDT Equity Inc. (CDT)
Nasdaq: CDT · Pharmaceutical Preparations · Naples, FL · filing with the SEC since 2021
Filings
304 filings since 2017 beside 67 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026Due next and emerging growth company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Oct 27, 2026.
Filings a yearinsider forms included
24087817190
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 5 times in the last 36 months, the newest Sep 1, 2026.Auditor change (8-K item 4.01): 2 times in the last 36 months, the newest Jun 29, 2026.Listing warning from its exchange (8-K item 3.01): 5 times in the last 36 months, the newest May 28, 2026.Warning not to rely on past financial statements (8-K item 4.02): 3 times in the last 36 months, the newest Aug 14, 2025.SEC letters: 17 in the last 36 months, the newest Apr 30, 2026.A late-filing notice, Form NT 10-Q, filed May 15, 2026.A late-filing notice, Form NT 10-K, filed Apr 1, 2026.A late-filing notice, Form NT 10-K, filed Apr 1, 2024.A late-filing notice, Form NT 10-Q, filed Nov 14, 2023.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 4, 2026
8-K items 3.03, 5.03, 9.01
Change to shareholders' rights; Charter, bylaw or fiscal-year change · Current report
Nov 2, 2026
Oct 27, 2026
8-K items 1.01, 3.02, 7.01, 9.01
Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Oct 22, 2026
Oct 13, 2026
8-K items 1.01, 2.03, 3.02, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report
Oct 6, 2026
Sep 25, 2026
8-K items 3.03, 5.03, 7.01, 9.01
Change to shareholders' rights; Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report
Sep 24, 2026
Sep 18, 2026
8-K items 1.01, 2.03, 3.02, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report
Sep 14, 2026
Sep 4, 2026
8-K items 1.01, 2.03, 3.02, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report
Aug 31, 2026
Sep 1, 2026
8-K items 5.02, 5.07, 9.01
Officer or director change; Shareholder vote · Current report
Aug 28, 2026
Aug 21, 2026
8-K/A item 9.01
Financial statements and exhibits · Current report, amended
Jul 30, 2026
Aug 21, 2026
8-K/A items 2.01, 9.01
Purchase or sale of a business completed · Current report, amended
Feb 19, 2026
Aug 6, 2026
8-K items 1.01, 2.03, 3.02, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report
Jul 31, 2026
Aug 3, 2026
8-K/A items 2.01, 9.01
Purchase or sale of a business completed · Current report, amended
Jul 30, 2026
40 of 304 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.